Time Table (0pening hour)

Time Table

Central Europe: Belgium, Bulgaria, Check republic, Croatia, Denmark, Estonia, Finland, France, Germany, Greece, Italy, Latvia,

Lithuania, Netherland, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine

16:00

United States East (New York) -6 hrs (10:00) Iraq, Saudi Arabia +2 hrs (18:00)

United States Central (Chicago) -7 hrs (09:00) Russia +2 hr (18:00)

United States Midwest (Texas, Minnesota) -8 hrs (08:00) Iran +2.5 hrs (18:30)

United States West (California) -9 hrs (07:00) India +4.5 hs (20:30)

Canada (Montreal, Toronto) -5 hrs (11:00) Sri-Lanka + 5 hrs (21:00)

Canada (Vancouver) -8 hrs (08:00) China +7hrs (23:00)

Brazil -3 hrs (13:00) Singapour, Taiwan, Phillipines +7hrs (23:00)

Great Britain, Ireland -1 hr (15:00) Japan, South Korea, Thailand, Indonnesia +8 hrs (24:00)

Nigeria 16:00 Australia +10 hr (02:00 next day)

Thursday, February 11

, 2021

Hall A

16:00-19:00

Meet the Experts (Additional Registration Fee)

Afshan Hameed, University California Irvine, USA 16:00-17:00 Valvular Heart Disease and Pregnancy

Uri Elkayam

17:00-17:30

Question and Answers and Panel Discussion Moderator: Uri Elkayam

Panelists: Catherine W. Arendt, Afshan Hameed 17:30-18:30 Pregnancy and Congenital Heart Disease

Candice Silversides 18:30-19:00

Question and Answers

Moderator: Candice Silversides

Panelists: Uri Elkayam, Katherine W. Arendt, Afshan Hameed

19:00-19:20

Break

Hall A

19:20-20:45

Opening Ceremony

Awards

Presentation of the CPP2021 Awards for Distinguished Contributions Presented by:

Uri Elkayam, Avi Shotan 19:40-20:34 Opening Lecture

25 years journey into the understanding of pregnancy associated acute myocardial infarction Uri Elkayam

University of Southern California, Los Angeles, USA

Hall A Hall B

20:36-22:43

Pulmonary Hypertension and Emboli

Risk Prediction, contraception and Maternal

Mortality

20:36-21:05

Diagnosis and Management of Pulmonary Embolism in Pregnancy

Timothy Fernandes

University California, San Diego, USA

20:36-20:52

Risk Prediction: Are we there Yet? Samuel Siu

Western University, London, Canada

21:05-21:27

Pregnancy and PAH – a Survivable Condition –Worldwide update

Dianne Zwicke

Aurora St. Luke’s Medical Center, Milwaukee, USA

20:52-21:11 Top 3 Causes of Maternal Mortality in the USA _{Afshan Hameed} University of California, Irvine, USA

21:27-21:44

Cardiovascular Implication for Covid-19 in Pregnancy Joan Briller

University of Illinois, Chicago, USA

21:11-21:31

Sociodemographic Disparities in Maternal Mortality in the US

Kathryn J. Lindley

Washington University, St Louis' Missouri, USA 21:44-22:05

Pulmonary Hypertension in Pregnancy: The Anesthesiologist's Perspective

Marie-Louise Meng

Columbia University Medical Center, New York, USA

21:31-21:46 Fertility Control in Women with Cardiovascular Disease _{Joan Briller} University of Illinois, Chicago, USA

22:05-22:43

Pregnancy and PAH – Management Protocol Dianne Zwicke

Aurora St. Luke’s Medical Center, Milwaukee, USA

21:46-22:01

Preconception Counseling – which Women should be advised to Avoid Pregnancy?

Candice Silversides

Mount Sinai Hospital, Toronto, Canada 22:01-22:23

Cardiac Evaluation during Pregnancy Uri Elkayam, MD

University of Southern California, Los Angeles, USA 22:23-22:41 Creating Cardiovascular Disease Screening Program

Afshan Hameed

Friday, February 12

, 2021

Hall A

Hall B

Hall C

16:00-18:00

Maternal Cardiology,

Reproduction, Sickle Cell and

Thalassemia

16:00-17:54

Arrhythmias

Vascular Disease during

Pregnancy

16:00-16:18

Maternal Cardiology: Gaps and Opportunities

Samuel Siu

Western University, London, Canada

16:00-16:40

Arrhythmia - Approach to Management in Pregnancy Danna Spears

Toronto General Hospital, Toronto, Canada

16:00-16:16

Marfan Syndrome and Pregnancy: Short and Long-Term Risks Rafael Kuperstein

Sheba Medical Center, Tel Aviv University, Ramat Gan, Israel

16:18-16:40

Maternal Cardiology Team: How to Build and why it is Necessary Diana Wolfe

Montefiore Medical Center, New York, USA

16:40-16:50

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) in

Pregnancy: A Case Series of Nine Patients in Calgary, Canada Angela Kealey

University of Calgary, Alberta, Canada 16:16-16:25

A Retrospective study of Aortic Events in Pregnant Women with Marfan Syndrome – does the Discrepancies in International Prophylactic Surgery Guidelines Matter?

Dorte Guldbrand

Aarhus University Hospital, Aarhus, Denmark

16:40-16:56

Biomarker Profile and Risk Stratification in Pregnancy Hasan Al-Farhan

Baghdad Teaching Hospital, Bagdad, Iraq

16:50-17:00

Mechanisms of Cardiac Arrhythmias in Pregnancy

Céline Fiset

University of Montreal, Montreal, Canada

16:25-16:33

Marfan Syndrome with Splenic Artery Aneurysms in Pregnancy - A case report

Tiyasha Hosne Ayub

University Hospital Bonn, Bonn, Germany

16:56-17:04

Creating a Maternal Cardiac Center of Excellence

Valerie Rader

St. Luke’s Hospital, University of Missouri, Kansas City, USA

17:00-17:21

Palpitations in Pregnancy Lee B Padove

Northside Hospital, Atlanta, USA 16:33-16:43

Management Dilemmas in a Pregnant Patient with Newly Diagnosed Loeys-Dietz Syndrome

Myo Lwin

University Hospital Southampton NHS Foundation Trust, Wessex, UK

17:04-17:20

The importance of Gyneco-Cardiology Collaboration – a Dedicated Women Cardiac Health Clinic

Avital Porter

17:21-17:27

Pregnancy Outcome in Women with Maternal Implantable Cardiac Defibrillators

Marta Lopez

16:43-17:00

Vascular Dissections and Aneurysms during Pregnancy

Afshan Hameed

Rabin Medical Center, Petach Tikva,

Israel BCNatal–Barcelona Center for Maternal-Fetal and Neonatal Medicine, Barcelona, Spain

17:20-17:29

Prediction of Adverse Obstetrical Outcomes in Pregnant Patients with Sickle Cell Disease Based on

Tricuspid Regurgitant Velocity – A Retrospective Cohort Study Vincent Williams

University of Montreal, Montreal, Canada

17:27-17:54 Syncope in Pregnancy - when to be Worried

Paul Gibson

University of Calgary, Calgary, Canada

17:00-17:10

Takayasu’s Arteritis in Pregnancy (Case)

Eryn Bryant

Stanford School of Medicine, Stanford, USA

17:29-17:50

Older Women Getting Pregnant means more Heart Disease

Norbert Gleicher

The Center for Human Reproduction, New York, USA

17:10-17:24

Is Turner Syndrome Still a

Significant Risk Factor for Dissection in Pregnancy: a Cohort Study of 130 Turner Syndrome Pregnancies? Matthew Cauldwell

Imperial College London

17:50-18:00

Cardiac Disease and Pregnancy Outcomes in a Contemporary Cohort of Thalassemia Patients

Inna Landres

Weill Cornell Medicine/New York Presbyterian, New York, USA

17:24-17:39

Turner Syndrome and Pregnancy Jolien Roos-Hesselink

Erasmus Medical Center, Rotterdam, The Netherlands

17:39-18:08

Aortic Dissection in Pregnancy Causes and Prevention

Sorel Goland, MD

Hebrew University, Jerusalem, Israel

18:05-18:25

Break

Hall A

Hall B

Hall C

18:25-19:57

Guidelines and Registries

Hypertension and Pregnancy

Vascular Disease and Surgery

during Pregnancy

18:25-18:58

2018 ESC Guidelines Cardiovascular Diseases during Pregnancy

Jolien Roos-Hesselink

Erasmus Medical Center, Rotterdam, The Netherlands

18:25-18:44

Hypertension and Preeclampsia Afshan Hammeed

University California Irvine, Irvine,

USA 18:25-18:35

Native Coarctation of the Aorta – Stenting in Pregnancy (Case) Francois Dos Santos

18:58-19:17

Worldwide PPCM Registry: a Status Report

Karen Sliwa

Hatter Institute of Cardiovascular Research in Africa,

Cape Town, South Africa

18:44-18:49

Risk Factors for Hypertension and it's Effects on Maternal Pregnancy Outcomes in Women with a History of Coarctation of the Aorta (ct) Scott Cohen

Medical College of Wisconsin, Milwaukee, USA

18:35-18:45

Pregnancy in Women with Total Cavopulmonary Connection Petra Antonova

University Hospital Kralovske , Vinohrady, Czech Republic

19:17-19:34

The HOPE Registry in the US Florio Karen

Saint Luke's Health System, Kansas

City, USA 18:49-18:58

Myocardial Structure, Function, Perfusion and Scar at Longer-term Follow-up in Women with History of Preeclampsia (ct)

Odayme Quesada

Cedars Sinai Medical Center Smidt Heart Institute, Los Angeles, USA

18:45-18:56

Diagnosis, Management and

Outcomes of May Turner Syndrome in Pregnant Patients: a Case Series (ct)

Laura Schmidt

Saint Luke’s Health System, University of Missouri-Kansas City, USA

19:34-19:49

Pregnancy and Labor in Women with Heart Diseases.

The Northern Israel Registry Eli Gutterman

Carmel Medical Center & Clalit Health Services, Haifa, Israel

18:58-19:07

Hypertensive pregnancy Disorders among Women with Heart Disease in Norway(ct)

Ingrid Langen

Oslo University Hospital, Oslo, Norway

18:56-19:00

Assisted Reproduction Techniques and Pregnancy in a Woman with Turner Syndrome and Congenital Heart Disease (Case)

Biancamaria D'Agata Mottolese Institute for Maternal and Child Health-IRCCS 'Burlo Garofolo', University of Trieste, Trieste, Italy, Italy

19:00-19:12

Takayasu’s Arteritis in Pregnancy Abha Khandelwal

Stanford University School of Medicine, Stanford, USA

19:12-19:21

Aortic Coarctation in Pregnancy: Outcomes and Predictors for Cardiovascular and Hypertensive Complications. Data from the ESC Registry of Pregnancy and Cardiac Disease (ROPAC) (ct)

Karishma Priyadarshani Ramlakhan Erasmus University Medical Center, Rotterdam, Netherlands

19:21-19:30 Urgent Cardiac Surgery and Pregnancy (ct)

Amosov National Institute for Cardio-vascular Surgery, Kiev, Ukraine

19:30-19:38

Peripartal Cardiac Surgery: a Compilation of Specialized

Multidisciplinary Treatment of 18 Cases in a Single Center

Paulina Wiktorowska

Leipzig Heart Center, Germany

19:40-20:00

Break

Hall A

Hall B

Hall C

20:10-21:15

Rapid Fire A

20:10-21:17

Rapid Fire B

Acute MI Pregnancy-Associated Myocardial Infarction (PAMI) in Alberta – A Detailed 15-Year Population-Based Study Utilizing the Approach Database (2003-2017)

Paul Gibson

University of Calgary, Canada

Congenital Pregnancy and Systemic Right Ventricle

Francois Dos Santos

Imperial College London, London, UK

Assisted Reproduction Techniques and Pregnancy in a Woman with Turner Syndrome and Congenital Heart Disease (Case 342) Marco Bobbo

Institute for Maternal and Child Health-IRCCS 'Burlo Garofolo', University of Trieste, Trieste, Italy, Italy

Medications Contraception in Women with Heart Disease - Do not be Afraid

Lynne Freeland Nelson

Saint Luke's Hospital of Kansas City, USA

Cardiac evaluation

Maternal Outcomes in Planned and Unplanned Pregnancies in Women with Cardiac Disease

Noor Joudi

Department of Obstetrics & Gynecology, Stanford University, Stanford, USA

PPCM הרמהב

Risk of Subsequent Pregnancy in Women with History of Peripartum Cardiomyopathy

Shamsa Alhinai

Royal Hospital, Muscat, Oman

Congenital

Risk Management of Pregnancy with Systemic Right Ventricle in Dextro-Transposition of the Great Arteries Miki Kanoh

Japanese Red Cross Saitama Hospital, Saitama, Japan

Cardiac Evaluation

Scottish Obstetric Cardiology Network – Improving Care for

Congenital A Successful Pregnancy in a Patient with Hypoplastic Right Ventricle

Women of Child-Bearing Age with Heart Disease in Scotland

Maggie Simpson

National Services Scotland, Glasgow, UK

with a One and a Half Ventricle Repair

Sumithra Jeganathan

Zucker School of Medicine at

Hofstra/Northwell, New York, USA Risk

assessment

Predictors of Long-term Maternal Cardiovascular Events in Women with Congenital Heart Disease

Hayley Schultz

University of California, San Francisco, US

A

Labor and Delivery

Anesthetic Intrapartum Management of Parturients with Fibrosing

Mediastinitis: A Case Series Miguel Teixeira

Mayo Clinic, Rochester, USA Acute MI The Implications of

Pregnancy-Associated Spontaneous Coronary Artery Dissection

Angie Lobo Mayo Clinic, USA

Congenital Experience with Pregnancy in Fontan Patients at One Centre

Natalie Bottega

McGill University Health Centre, Montreal, Canada

Acute MI Spontaneous Coronary Artery Dissection when Associated with Pregnancy

Matthew Cauldwell

Imperial College London, UK

The Association of Non-dipping Pattern of Blood Pressure in Gestational Hypertension on Early Onset of Hypertension Later in Life Djordje Ilic

Novi Sad, Institute of Cardiovascular Diseases of Vojvodina, University of Novi Sad, Novi Sad, Serbia

Risk

assessment

Familial Hypercholesterolemia in Pregnancy: Case Series

Mary Nangrahary

King Edward Memorial Hospital, University of Western Australia, Subiaco, Australia

Congenital Severe Placentomegaly and

Intraterine Growth Restriction in a Persistently Hypoxemic Pregnant Woman with Single Cardiac Ventricle Eli Gutterman

Clalit Health Services, Carmel Medical Center, Israel

Coronary Artery Disease

Pregnancy in A woman With

Hemoglobinopathy SS and Idiopathic Aortitis after Coronary Artery Bypass Grafting

Joanne Quinones

Lehigh Valley Health Network, University of South Florida Morsani College of Medicine Tampa, USA

Labor and delivery

Are all the Clinical Indications for C-sections in Cardiac Patients

Appropriate? A Review of a

Multidisciplinary Italian Experience Francessca Maria Comoglio

Myocarditis Myocarditis in Pregnancy: Case Series

Polona Koritnik

University Medical Center Ljubljana, Slovenia

Valvular Mechanical Heart Valves in

Pregnancy: A Single Center Cohort Elisabeth Codsi

Sainte-Justine Hospital, Montreal, Canada

Risk assessment

Risk of Obstetric Complications during Pregnancy in Women with Heart Disease

Berta Serrano

Hospital Universitari Vall d'Hebron, Spain

Valvular Infective Endocarditis and Pregnancy

Sergii Siromakha

National Amosov Institute of Cardio-vascular Surgery, Kyiv, Ukraine Hypertension Preventative Care after

Hypertensive Disorders of

Pregnancy: Do Women Go and what do they Hear?

Jourdan Triebwasser

Maternal and Child Health Research Center, Perelman School of Medicine, University of Pennsylvania, USA Risk

assessment

Joint Cardiology Obstetric Clinic Supports Women with Suspected or Diagnosed Cardiac Conditions through Pregnancy

Diane Barker

University Hospitals of North Midlands, Stoke-on-Trent, UK

Saturday, February 13

, 2021

Hall A

Hall B

Hall C

16:00-18:34

Congenital Heart Disease

16:00-16:17

Genetics of Adult Congenital Heart Disease: Pregnancy Considerations Candice Silversides

Mount Sinai Hospital, Toronto, Canada 16:00-16:05

Labor and Delivery Outcomes in Pregnant Women with Cardiac Disease (ct)

Salman Hashim

Mount Sinai Hospital, Toronto, Canada

Risk Assessment 16:00-16:10

Recurrence of Atrial Myxoma in IVF Pregnancy: A Unique Case of

Successful Antepartum Anticoagulation Regimen and Postpartum Resection Noor Joudi

Department of Cardiology, Stanford University, Stanford, USA

16:17-16:35

Maternal and Fetal Flows in

Congenital Heart Disease: what can Cardiovascular Magnetic Resonance Imaging Teach us?

Rachel Wald

Toronto General Hospital, Toronto, Canada

16:05-16:21

How to Organize Cardiac ICU on Labor Floor?

Amir Shamshirsaz

Baylor College of Medicine, Houston, Texas, USA

Valvular 16:10-16:21

Parachute Mitral Valve, Mitral Regurgitation Mirror Syndrome in Pregnancy

Nicolo' Montali

Città della Salute e della Scienza di Torino, Torino, Italy

16:35-16:55

Pregnancy in Women with Left to Right Shunts: any Risk?

Marla Mendelson

Northwestern Feinberg School of Medicine, Chicago, USA

16:21-16:37

How does the OB Anesthesiologist Plan for Delivery?

Marie-Louise Meng

Columbia University Medical Center, New York, USA

Congenital & Arrhythmias 16:21-16:39

Multidisciplinary Management and Multi-site Care of a Pregnancy in a Patient with Fontan’s Circulation, an Aortic Homograft and Paroxysmal Atrial Arrhythmia

Fiona O'Toole

Rotunda Hospital, Dublin, Ireland

16:55-17:11

Should Patients with TOF and Severe PR have Valve Replacements Prior to Pregnancy?

Sabrina Phillips

Mayo Clinic Congenital Heart Disease Center, Rochester, USA

16:37-17:05

Sympathectomy from Neuraxial Anesthesia: Implication for the Cardiac Parturient

Katherine W Arendt

Mayo Clinic, Rochester, USA

Arrhythmias 16:39-16:48

Second Trimester Placement of a Subcutaneous Implantable

Defibrillator in a Woman with Long Qt Syndrome

Amy Ahnert

Lehigh Valley Health Network, University of South Florida Morsani College of Medicine, Tampa, USA 17:11-17:28 Pregnancy in Patients with a Systemic

RV 17:05-17:21

Hemodynamics Peri-Delivery: The Anesthesiologist's Perspective

DVT 16:48-16:55

Peripartum Anesthetic Management of a Parturient with Cardiac

Carole Warnes

Mayo Clinic, Rochester, USA Marie-Louise Meng Columbia University Medical Center, New York, USA

Angiosarcoma and Heparin Induced Thrombocytopenia

Amber C Benhardt

Washington University in St. Louis School of Medicine, St. Louis, USA

17:28-17:37

Pregnancy Outcomes in Female Heart Recipients Transplanted for Peri-Partum Cardiomyopathy (PPCM) Michael Moritz

Transplant Pregnancy Registry International, Lehigh Valley Health Network, Allentown, USA

17:21-17:40

Critical Illness in Pregnancy:

Implications of Acid/Base Status on the Utero-placental Unit

Katherine W Arendt

Mayo Clinic, Rochester, USA

Congenital 16:55-17:01

Congenital Heart Disease and Pregnancy

Lisa Sophie Barthel

University Clinic Bonn, Bonn, Germany

17:37-17:46

Pregnancy Outcomes in Women with Arrhythmias Following Surgical Repair of Cardiac Defects (ct) Rebecca Chornock

MedStar Washington Hospital Center, Washington, USA

17:40-18:02

Optimal Timing for Delivery: 37-39-41?

Mordechai Hallak

Hillel Yaffe Medical Center, Hadera, Israel

Congenital 17:01-17:15

Patient with Pathogenic ACTA2 Variant: Twice Pregnant, Twice at Risk!

Francesca Bonassin Tempesta University Hospital Zurich, Switzerland

17:46-18:12

Pregnancy in Women with Systemic Right Ventricle

Michael Gatzoulis, MD, PhD Royal Brompton hospital, London, United Kingdom

18:02-18:20

Cardiac Effects of Drugs used for Induction of Labour and Prevention and Treatment of Postpartum Hemorrhage

Matthew Cauldwell

Imperial College London, London, United Kingdom

Hypertension

17:15-17:25 Primary Mediastinal Large B-cell Lymphoma in Pregnancy Complicated by Preeclampsia

Lakha Prasannan

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, USA

18:12-18:34

Pregnancy in Patients with Fontan Physiology: Prognosis and

Management

Candice Silversides, MD

University of Toronto, Toronto, Canada

Vascular 17:25-17:34

Takayasu’s Arteritis with Aortic Aneurysm in Pregnancy:

a Case Report Luísa Andrade Silva

Hospital de São Bernardo, Centro Hospitalar de Setúbal, EPE, Portugal PPCM

17:34-17:41

CardioMEMS as an Aid to Clinical Management in a Pregnancy with Pre-Existing Peripartum

Cardiomyopathy Ruchira Sharma

Zucker School of Medicine at Hofstra/Northwell, USA

PPCM 17:41-17:51

Management of a Parturient with Acute Decompensated Heart Failure, Peripartum Cardiomyopathy and Pre-eclampsia with Severe Features Rochelle (Molitor) Pompeian Mayo Clinic, Rochester, USA PPCM

17:51-17:59

A Case of Peripartum

Cardiomyopathy in a Woman with VSD

Saria Kawano

Tokyo Metropolitan Bokutoh Hospital, St. Luke's International Hospital, Tokyo,Japan

18:30-18:50 Break

18:50-19:39

Congenital Heart Disease

Cardiomyopathy and Heart

Failure during Pregnancy

Post Atrial Switch Operation Carole Warnes

Mayo Clinic, Rochester, USA 18:50-19:06

Acquired and Reversible

Noncompaction of Left Ventricle in Pregnancy

Radha Sarma

Western University of Health Sciences, Los Angeles, USA

Arrhytmias

19:08-19:18 How Pregnancy Impacts Adults with Cyanotic Congenital Heart Disease Magalie Ladouceur

Hôpital Européen Georges Pompidou, Paris, France

19:06-19:12

Management and Outcome of Acute and Recurrent Pericarditis during Pregnancy (ct)

Rafaek Kuperstein

Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel 19:18-19:39 Development of Delivery Plans for

Women with Complex Heart Disease: Fontan, TGA

Mary Canobbio

University of California Los Angeles, Los Angeles, USA

19:12-19:29

Pregnancy after Heart Transplantation

Michael Moritz

University of South Florida Morsani College of Medicine, Tampa, USA

19:39-20:43

Coronary Artery Disease and

Pregnancy

19:29-19:51

Hypertrophic Cardiomyopathy and Pregnancy

Sorel Goland

Kaplan Medical Centre, Rehovot, Israel

19:39-20:05

SCAD Associated with Pregnancy vs Non-Pregnancy Associated SCAD-The Mayo Clinic Experience Marysia S Tweet

Mayo Clinic, Rochester, USA

19:51-19:59

Perinatal Outcomes of Women with Hypertrophic Cardiomyopathy Emilie L'Écuyer

Sainte-Justine University Hospital / University of Montreal, Montreal, Canada

20:05-20:13

Pregnancy after Spontaneous Coronary Artery Dissection Matthew Cauldwell

Imperial College London

19:59-20:18

Dilated (Non-PPCM) Cardiomyopathy and Pregnancy

Avraham Shotan

Laniado Medical Center, Netanya, Israel

20:13-20:25

Cardiac Interventions Pregnancy Anil Mehra

University of Southern California, Los

Angeles, USA 20:18-20:35

Pregnancy Outcomes in Female Heart Recipients Transplanted for Peri-Partum Cardiomyopathy (PPCM)

Michael Moritz University of South Florida Morsani

College of Medicine, Tampa, USA 20:25-20:43

Outcome of Pregnancy in Women with an History of SCAD

Marysia S Tweet

Mayo Clinic, Rochester, USA

20:43-20:55 Break

20:55-22:26

Arrhytmias

20:55-21:30

Inherited Arrhythmia Syndromes- Approach to Management in Pregnancy

Danna Spears

Toronto General Hospital, Toronto, Canada

21:30-21:42

ICD Management Labor and Delivery Mary Canobbio

University of California, Los Angeles, Los Angeles, USA

21:42-22:05

Anti-Ro and anti-La and the Risk of Fetal/Neonatal Heart Block

Michal Simchen

Sheba Medical Center, Ramat Gan, Israel

22:05-22:26 Cardiac Arrest Pregnancy Joan Briller

Sunday, February 14

, 2021

Hall A

Hall B

16:00-18:47

Peripartum Cardiomyopathy

Cardiovascular Therapy during Pregnancy

Highlights from the ESC 2019 Position Paper on PPCM Johann Bauersachs

Medical School Hannover, Hannover, Germany 16:00-16:23

Update on Drugs in Pregnancy: Pharmacokinetics, Precision Dosing & Fetal Exposure Irving Steinberg

University of Southern California, Los Angeles, USA 16:18-16:33 Epidemiology of Peripartum Cardiomyopathy _{Maria Schaufelberger}

University of Gothenburg, Gothenburg, Sweden 16:23-16:45

The Use of Beta- blockade for Cardiovascular Disease during Pregnancy

Marla Mendelson

Northwestern Feinberg School of Medicine, Chicago, USA

16:33-16:48

Peripartum Cardiomyopathy: Clinical Presentation, Management and 6-Month Outcome of Women Diagnosed with PPCM from Europe, Africa, Asia Pacific and the Middle East

Karen Sliwa

Hatter Institute of Cardiovascular Research in Africa, Cape Town, South Africa

16:45-17:01

Safety Considerations in the Selection of Cardiac Drugs during Pregnancy and Lactation

Lisa Levine

University of Pennsylvania, Philadelphia, USA

16:48-17:17 Debate: Is Bromocriptine Ready for Prime Time? 17:01-18:47

Valvular Heart Disease and Anticoagulation

Johann Bauersachs

Medical School Hannover, Hannover, Germany 17:01-17:18

Pregnancy in Women with Prosthetic Heart Valve Uri Elkayam

University of Southern California, Los Angeles, USA 17:01-17:17

Con:

Dennis McNamara

University of Pittsburgh, Pittsburgh, USA 17:18-17:44

Anticoagulation in Pregnant Women with Mechanical Prosthetic Valves

Candice Silversides, MD

University of Toronto, Toronto, Canada

17:17-17:26

Clinical Profile and Outcomes of Peripartum Cardiomyopathy in Nigeria: a Prospective Longitudinal Study (ct)

Kamilu Karaye

Aminu Kano Teaching Hospital, Nigeria

17:44-17:54

The Challenge of Accurate Diagnostic Imaging for Valvular Disease during Pregnancy (ct)

Amy Ahnert

Lehigh Valley Health Network, Allentown, USA

17:26-17:33 Contemporary Outcome of Subsequent Pregnancies in Patients with a History of Peripartum

Cardiomyopathy (ct)

17:54-18:06

Management of Anticoagulation for Pregnant Women with Mechanical Heart Valves: Experience from a Single Center in South India (ct)

Rafael Kuperstein

Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel

Anish Keepanasseril

Jawaharlal Institute of Postgraduate Medical

Education and Research (JIPMER), Pondicherry, India

17:33-17:52 Genetics of Peripartum Cardiomyopathy_{Zoltan Arany} University of Pennsylvania, Philadelphia, USA

18:06-18:26

Outcomes in Women with Mechanical Heart Valves Anticoagulated with Low Molecular Weight Heparin during Pregnancy (ct)

Rohan D'Souza

Mount Sinai Hospital, University of Toronto, Canada

17:52-18:19

Why Peripartum Cardiomyopathy is Likely an Autoimmune Disease

Norbert Gleicher

The Center for Human Reproduction, New York, USA

18:26-18:36

Infective Endocarditis in Pregnancy: A Contemporary Cohort (ct)

Malamo Countouris

University of Pittsburgh, Pittsburgh, USA 18:19-18:35

Genomic Background, Race and Recovery in Peripartum Cardiomyopathy

Dennis McNamara

University of Pittsburgh, Pittsburgh, USA

18:36-18:47

Mechanical Mitral Valve Thrombosis in Pregnancy: what Now? (case)

Lukas Meier

University Hospital Zürich, Zurich, Switzerland 18:35-18:47

Peripartum Cardiomyopathy: Long-term Survival, Recovery & Duration of Medical Therapy

Melinda Davis

University of Michigan, Ann Arbor, USA

20:35-20:55 Break

19:10-21:35

Peripartum Cardiomyopathy

Valvular Heart Disease and Anticoagulation

Zoltan Arany

University of Pennsylvania, Philadelphia, USA

19:10-19:28 2018 ESC Guidelines for Anticoagulation in Pregnant Women with Mechanical Prosthetic Heart Valves – Petronella G (Els) Pieper

University Medical Center, Groningen, The Netherlands

19:29-19:58

Management of Severe Heart Failure/Cardiogenic Shock in Pregnancy

Uri Elkayam

University of Southern California, Los Angeles, USA

19:28-19:35

Double Trouble: Mitral Stenosis and Left

Ventricular Outflow Tract Obstruction in Pregnancy from a Bio-prosthetic Mitral Valve (Case)

Jonathan Windram

University of Alberta, Edmonton, Canada

19:58-20:11

The Evidence of Subclinical LV Dysfunction in PPCM with Recovered EF

Sorel Goland

Kaplan Medical Centre, Rehovot, Israel

19:35-19:44

Mechanical Mitral Valve Thrombosis and

Endocarditis during Pregnancy: a Case Report (Case) Sofia Torres

Centro Hospitalar Universitário De São João, Porto, Portugal

20:11-20:26

PPCM: Anticoagulation: Sudden Cardiac Death Melinda B. Davis

University of Michigan, Ann Arbor, USA 19:44-20:01

Catheter Based Interventions for Valvular Disease in Pregnancy

Anil Mehra

University of Southern California, Los Angeles, USA

20:26-20:51

PPCM-The Risk of Subsequent Pregnancy – To be or not to be?

Uri Elkayam

University of Southern California, Los Angeles, USA

20:51-21:00

Closing Remarks